WHO Prequalifies key treatment for children with TB
M
WHO has just prequalified a two-pills-in-one paediatric medicine that is critical for the continuation phase of the six-month treatment required to cure tuberculosis (TB).
Key performance indicators for WHO prequalification
M
In the interest of monitoring performance and increasing its capacity to report on that performance to its many stakeholders, the WHO Prequalification Team has developed new key performance indicat
First generic sofosbuvir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Shanghai Desano’s lamivudine/zidovudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hetero's ritonavir 100mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Hetero's moxifloxacin 400mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Newly prequalified Quality Control Laboratories (QCLs)
M
New additions to the List of Prequalified Quality Control Laboratories (QCL):